Atai Life Sciences N.V. (ATAI)

Atai Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	61.94	17.51	45.03	190.61	362.27	97.25
Short-Term Investments	34	44.83	134.22	82.5	-	-
Cash & Short-Term Investments	95.94	62.33	179.26	273.11	362.27	97.25
Cash Growth	8.60%	-65.23%	-34.36%	-24.61%	272.52%	223.48%
Other Receivables	-	1.35	1.75	5.63	5.41	1.07
Receivables	-	1.35	2.26	5.63	6.32	1.29
Prepaid Expenses	6.74	0.77	1.41	2.03	3.05	0.14
Restricted Cash	-	10	-	-	-	-
Other Current Assets	-	5.68	2.67	6.37	3.45	0.87
Total Current Assets	102.68	80.13	185.59	287.15	375.08	99.55
Property, Plant & Equipment	5.7	3.87	2.2	1.15	0.15	0.07
Long-Term Investments	70.76	70.97	91.66	6.76	27.76	8.04
Goodwill	0.33	0.33	-	-	-	-
Other Intangible Assets	3.12	3.25	1.77	-	-	-
Long-Term Deferred Charges	-	-	-	-	-	1.58
Other Long-Term Assets	6.61	0.85	0.95	3.13	7.34	0.34
Total Assets	189.2	159.39	293.48	305.44	414.17	111.55
Accounts Payable	4.04	2.62	4.59	2.4	6	3.08
Accrued Expenses	14.51	9.66	14.54	15.08	6.69	8.22
Current Portion of Long-Term Debt	-	9.36	-	-	-	-
Current Portion of Leases	0.44	0.48	0.28	0.18	-	-
Current Income Taxes Payable	-	0.19	0.72	2.22	8.14	1
Other Current Liabilities	0.4	2.65	-	0.01	0.1	-
Total Current Liabilities	25.55	24.95	20.12	19.9	20.94	12.3
Long-Term Debt	-	16.33	20.08	17.52	3.14	2.18
Long-Term Leases	2.62	0.73	0.99	0.04	-	-
Other Long-Term Liabilities	17.11	0.82	7.98	2.22	4.13	1.71
Total Liabilities	45.28	42.83	49.16	39.68	28.21	16.18
Common Stock	143.74	18.79	18.57	18.56	18	13.37
Additional Paid-In Capital	-	816.19	794.79	774.09	725.05	261.63
Retained Earnings	-	-700.21	-550.94	-510.19	-357.8	-190
Comprehensive Income & Other	-	-18.47	-19.46	-21.73	-8.34	5.82
Total Common Equity	143.74	116.3	242.96	260.74	376.91	90.82
Minority Interest	0.19	0.26	1.35	5.03	9.05	4.55
Shareholders' Equity	143.93	116.55	244.32	265.77	385.96	95.37
Total Liabilities & Equity	189.2	159.39	293.48	305.44	414.17	111.55
Total Debt	9.22	26.91	21.34	17.74	3.14	2.18
Net Cash (Debt)	86.73	35.42	157.92	255.37	359.12	95.07
Net Cash Growth	30.59%	-77.57%	-38.16%	-28.89%	277.75%	217.90%
Net Cash Per Share	0.50	0.22	0.99	1.64	2.60	1.02
Filing Date Shares Outstanding	196.56	198.31	166.03	166.01	160.71	11.47
Total Common Shares Outstanding	196.56	167.96	166.03	165.94	160.68	11.47
Working Capital	77.13	55.17	165.47	267.25	354.15	87.25
Book Value Per Share	0.73	0.69	1.46	1.57	2.35	7.92
Tangible Book Value	140.29	112.72	241.19	260.74	376.91	90.82
Tangible Book Value Per Share	0.71	0.67	1.45	1.57	2.35	7.92
Machinery	-	2.93	1.13	-	-	-

Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q